What investigations are used to diagnose polycythaemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Investigations for Polycythaemia

The diagnosis of polycythaemia requires a complete blood count (CBC) with differential, JAK2 mutation testing, and serum erythropoietin level as first-line investigations, followed by bone marrow biopsy for confirmation in most cases. 1

Initial Diagnostic Approach

  1. Complete Blood Count (CBC) with differential:

    • Confirms erythrocytosis: Hemoglobin >16.5 g/dL or hematocrit >49% in men, or >16 g/dL or >48% in women 2
    • Assesses other cell lines (leukocytosis, thrombocytosis)
    • Includes peripheral blood smear examination
  2. Serum Erythropoietin Level:

    • Critical for distinguishing between primary and secondary polycythaemia
    • Subnormal EPO is a minor diagnostic criterion for polycythaemia vera (PV)
    • Normal or elevated EPO suggests secondary polycythaemia
  3. JAK2 Mutation Testing:

    • Test for JAK2 V617F or exon 12 mutations
    • Present in >95% of PV cases 1, 2
    • Essential for distinguishing primary from secondary causes

Confirmatory Testing

  1. Bone Marrow Aspirate and Biopsy:

    • Required for definitive diagnosis, especially when:
      • JAK2 mutation testing is negative but clinical suspicion remains high
      • Distinguishing between different myeloproliferative neoplasms is necessary
    • Characteristic findings in PV include:
      • Hypercellularity
      • Increased megakaryocytes with cluster formation
      • Giant megakaryocytes
      • Pleomorphic megakaryocyte morphology
      • Decreased iron stores
      • Cytogenetic abnormalities (present in 13-18% of patients) 1
  2. Red Cell Mass and Plasma Volume Measurement:

    • May be required in ambiguous cases to differentiate primary, secondary, and combined polycythaemia 3
    • Less commonly performed since the advent of JAK2 testing

Additional Investigations for Secondary Causes

If JAK2 mutation is negative and/or EPO is normal/elevated, investigate for secondary causes:

  1. Chest X-ray:

    • To evaluate for cardiopulmonary disease causing hypoxia 3
  2. Arterial Blood Gas Analysis:

    • To assess for hypoxemia
  3. Sleep Study:

    • If obstructive sleep apnea is suspected
  4. Abdominal Ultrasound:

    • To evaluate for renal or hepatic pathology
    • To assess for splenomegaly
  5. Genetic Testing for Congenital Causes:

    • High-oxygen-affinity hemoglobins
    • Congenital erythrocytosis

Diagnostic Algorithm

  1. Initial Suspicion:

    • Elevated hemoglobin/hematocrit above the 95th percentile adjusted for sex and race
    • Documented increase in hemoglobin/hematocrit above patient's baseline
  2. First-line Testing:

    • CBC with peripheral blood smear
    • JAK2 V617F mutation testing
    • Serum erythropoietin level
  3. Interpretation:

    • If JAK2 mutation positive + low EPO: Likely PV, proceed to bone marrow biopsy
    • If JAK2 mutation negative + low EPO: Consider JAK2 exon 12 testing, then bone marrow biopsy
    • If JAK2 mutation negative + normal/high EPO: Investigate secondary causes

Common Pitfalls and Caveats

  • Relative Polycythaemia: Can occur due to dehydration or diuretic use, causing hemoconcentration. Always ensure proper hydration before testing.

  • Iron Deficiency: Repeated phlebotomies without diagnosis can lead to iron deficiency, decreased oxygen-carrying capacity, and increased stroke risk 1. Always check iron studies.

  • Masked Polycythaemia: Concurrent iron deficiency can mask true polycythaemia. Consider this in patients with borderline hemoglobin/hematocrit values.

  • Secondary vs. Primary: Never assume secondary polycythaemia without appropriate testing, as PV can coexist with conditions that typically cause secondary polycythaemia.

  • Bone Marrow Biopsy Timing: While guidelines recommend bone marrow biopsy for confirmation, in practice, this may be deferred in cases with clear JAK2 mutation positivity, low EPO, and typical blood count findings 2, 4.

References

Guideline

Diagnosis and Management of Polycythemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Deciphering polycythemia.

Hospital practice (1995), 1996

Research

Polycythaemia vera.

Nature reviews. Disease primers, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.